The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Sat., Aug. 17, 10:48 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #48. Baxter International Inc. Chatham Therapeutics

Acquirer: Baxter International Inc. (NYSE:BAX)
Acquiree: Chatham Therapeutics
Details: Baxter International Inc. (NYSE:BAX) and Chatham Therapeutics, LLC, today announced that Baxter has agreed to acquire all of Chatham's outstanding membership interests. As a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia.

Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. Co. manages its business based on three geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific.

Baxter International SEC Filing Email Alerts Service


Open the BAX Page at The Online Investor »

Company Name: 
Baxter International Inc
Stock buyback: 
BAX buyback
Website: 
www.baxter.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding BAX: 
112
Total Market Value Held by ETFs: 
$4.49B
Total Market Capitalization: 
$43.83B
% of Market Cap. Held by ETFs: 
10.26%
 

Open the BAX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.17 out of 4)
47th percentile
(ranked lower than approx. 53% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 48 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.